- Home
- QGEN
QGEN
Qiagen N.V.
as 11-20-2024 4:00pm EST
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).
| Founded: | 1986 | Country: | Netherlands |
| Employees: | N/A | City: | N/A |
| Market Cap: | 9.7B | IPO Year: | 1996 |
| Target Price: | $51.05 | AVG Volume (30 days): | 917.8K |
| Analyst Decision: | Buy | Number of Analysts: | 9 |
| Dividend Yield: | Dividend Payout Frequency: | N/A | |
| EPS: | 0.41 | EPS Growth: | -72.27 |
| 52 Week Low/High: | $39.03 - $47.44 | Next Earning Date: | 11-06-2024 |
| Revenue: | $1,966,174,000 | Revenue Growth: | 0.62% |
| Revenue Growth (this year): | 2.68% | Revenue Growth (next year): | 5.95% |
Latest Qiagen N.V. News
QGEN Breaking Stock News: Dive into QGEN Ticker-Specific Updates for Smart Investing
Zacks
8 days ago
QGEN Collaborates With McGill University Centre: Stock to Gain?
MT Newswires
8 days ago
Qiagen Partners With McGill University for Microbiome Research
GlobeNewswire
9 days ago
QIAGEN collaborates with McGill University to advance microbiome research
Zacks
10 days ago
Don't Overlook Qiagen (QGEN) International Revenue Trends While Assessing the Stock
Simply Wall St.
12 days ago
Qiagen Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
TipRanks
12 days ago
Qiagen’s Financial Growth and Rising Debt in Q3 2024
Zacks
13 days ago
Why Qiagen (QGEN) is a Top Value Stock for the Long-Term
GuruFocus.com
13 days ago
Qiagen NV (QGEN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements
Compare QGEN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "QGEN Qiagen N.V. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.